| 1. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 2-2
&NA;,
Preview
|
PDF (1156KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 2. |
Liposomal amphotericin B outperforms conventional formulation |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 3-3
Robert Carlson,
Preview
|
PDF (1044KB)
|
|
摘要:
The first study to compare 4 currently available amphotericin B formulations in an animal model has revealed that the 3 liposomal formulations outperform the conventional formulation of the antifungal drug. The study was conducted by US researchers from the California Institute for Medical Research and from Stanford University Medical School. Their findings were discussed at the recent Focus on Fungal Infections Conference [San Antonio, US; March 1997].
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 3. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 4-4
&NA;,
Preview
|
PDF (1057KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 4. |
Australian Asthma Management Plan: ongoing research needed |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 5-5
&NA;,
Preview
|
PDF (1053KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 5. |
QOL in epilepsy: room for improvement |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 6-6
&NA;,
Preview
|
PDF (954KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 6. |
Sirolimus ‘superior to cyclosporin’ in graft survival |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 7-7
&NA;,
Preview
|
PDF (948KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 7. |
News in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 8-8
&NA;,
Preview
|
PDF (1077KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 8. |
Naratriptan provides effective migraine control |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 9-10
Larry Prescott,
Preview
|
PDF (2185KB)
|
|
摘要:
A number of recent clinical trials have demonstrated that naratriptan [Glaxo Wellcome], a new potent and selective 5HTIB/IDagonist with a high oral bioavailability and improved pharmacokinetics, provides greater efficacy and enhanced tolerability in the treatment of migraine headache, when compared with placebo or sumatriptan, which is the present gold standard for migraine therapy. The results of these studies were presented at the 49th Annual Meeting of the American Academy of Neurology [Boston, US; April 1997].
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 9. |
Doxorubicin + anti-Fas MoAb synergy in bladder cancer |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 10-10
&NA;,
Preview
|
PDF (1145KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
| 10. |
Bromfenac in brief… |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1084,
1997,
Page 11-11
&NA;,
Preview
|
PDF (1015KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1997
数据来源: ADIS
|
首页
